Page last updated: 2024-08-25

rosiglitazone and Myelodysplastic Syndromes

rosiglitazone has been researched along with Myelodysplastic Syndromes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clevidence, DE; Juckett, MB; Lucarelli, MJ	1

Other Studies

1 other study(ies) available for rosiglitazone and Myelodysplastic Syndromes

Article	Year
Marrow suppression with myelodysplastic features, hypoerythropoetinemia, and lipotrophic proptosis due to rosiglitazone. WMJ : official publication of the State Medical Society of Wisconsin, 2009, Volume: 108, Issue:9 Topics: Diabetes Mellitus, Type 2; Erythropoietin; Exophthalmos; Female; Humans; Hypoglycemic Agents; Lipodystrophy; Middle Aged; Myelodysplastic Syndromes; Rosiglitazone; Thiazolidinediones	2009

Article

Year

Marrow suppression with myelodysplastic features, hypoerythropoetinemia, and lipotrophic proptosis due to rosiglitazone.

WMJ : official publication of the State Medical Society of Wisconsin, 2009, Volume: 108, Issue:9

Topics: Diabetes Mellitus, Type 2; Erythropoietin; Exophthalmos; Female; Humans; Hypoglycemic Agents; Lipodystrophy; Middle Aged; Myelodysplastic Syndromes; Rosiglitazone; Thiazolidinediones

2009